WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H471095
CAS#: 1621002-24-1
Description: PF-06658607 is an alkynylated irreversible Brutons tyrosine kinase (BTK) inhibitor.
Hodoodo Cat#: H471095
Name: PF-06658607
CAS#: 1621002-24-1
Chemical Formula: C27H24N6O2
Exact Mass: 464.20
Molecular Weight: 464.530
Elemental Analysis: C, 69.81; H, 5.21; N, 18.09; O, 6.89
Synonym: PF-06658607; PF06658607; PF 06658607,
IUPAC/Chemical Name: (R)-1-(3-(4-amino-3-(4-(3-ethynylphenoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
InChi Key: SFTPIUYKBLYRKF-HXUWFJFHSA-N
InChi Code: InChI=1S/C27H24N6O2/c1-3-18-7-5-9-22(15-18)35-21-12-10-19(11-13-21)25-24-26(28)29-17-30-27(24)33(31-25)20-8-6-14-32(16-20)23(34)4-2/h1,4-5,7,9-13,15,17,20H,2,6,8,14,16H2,(H2,28,29,30)/t20-/m1/s1
SMILES Code: C=CC(N1C[C@H](N2N=C(C3=CC=C(OC4=CC=CC(C#C)=C4)C=C3)C5=C(N)N=CN=C52)CCC1)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 464.53 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |